DENTSPLY SIRONA Inc.
- Stock
- Ticker XRAY
- ISIN US24906P1093
- Nasdaq
Performance, volatility and drawdowns of DENTSPLY SIRONA Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $1,593. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −86.6% in 11/2026, measured from the peak in 05/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 905 | 879 | 936 | 904 | 961 | 880 | 898 | 836 |
| Gross profit | 446 | 466 | 490 | 441 | 443 | 427 | 493 | 443 |
| Operating income | -509 | 63 | -128 | -218 | -139 | -35 | 82 | 37 |
| EBITDA | -421 | 142 | -40 | -126 | -46 | 44 | 167 | 119 |
| Net income | -430 | 20 | -45 | -427 | -146 | -10 | 37 | -2.0 |
| Earnings per share | -2.13 | 0.10 | -0.22 | -2.14 | -0.73 | -0.05 | 0.18 | -0.01 |
| Balance sheet | ||||||||
| Total assets | 5,753 | 6,050 | 6,069 | 5,653 | 5,429 | 5,229 | 5,204 | 5,190 |
| Liabilities | 3,810 | 4,040 | 4,108 | 4,175 | 4,089 | 3,910 | 3,853 | 3,836 |
| Equity | 1,942 | 2,010 | 1,960 | 1,478 | 1,339 | 1,318 | 1,351 | 1,355 |
| Cash | 272 | 398 | 359 | 363 | 326 | 190 | 239 | 195 |
| Long-term debt | 1,586 | 1,593 | 2,218 | 2,017 | 2,015 | 2,006 | 1,996 | 1,985 |
| Cash flow | ||||||||
| Operating cash flow | 87 | 7.0 | 48 | 79 | 101 | 40 | 99 | 32 |
| Capital expenditure | -51 | -19 | -32 | -39 | -41 | -52 | -44 | -32 |
| Free cash flow | 36 | -12 | 16 | 40 | 60 | -12 | 55 | 0.0 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2019 at +53.1%, weakest 2024 at −45.3%. 4 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 5 Nov 2026 | −$0.01 |
| 6 Aug 2026 | $0.18 |
| 5 May 2026 | −$0.05 |
| 26 Feb 2026 | −$0.73 |
| 6 Nov 2025 | −$2.14 |
| 7 Aug 2025 | −$0.22 |
| 8 May 2025 | $0.10 |
| 27 Feb 2025 | −$2.13 |
| 7 Nov 2024 | −$2.46 |
| 31 Jul 2024 | −$0.02 |
| 2 May 2024 | $0.09 |
| 29 Feb 2024 | $0.32 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €1.5bn
- Market cap in trading currency
- $1.64bn
- Enterprise value
- $3.65bn
- P/E
- –
- P/S
- 0.46
- P/B
- 1.21
- EV/Sales
- 1.02
- EV/EBITDA
- 12.8
- Earnings yield
- –
- FCF yield
- 6.3%
Results (last four quarters)
- Revenue
- $3.58bn
- Gross profit
- $1.81bn
- EBITDA
- $284m
- Net income
- −$121m
- Earnings per share
- −$0.61
- Revenue per share
- $18.04
- Revenue growth
- −7.5%
- Earnings growth
- –
Profitability
- Gross margin
- 50.5%
- Operating margin
- -1.5%
- Net margin
- -3.4%
- Return on equity
- -8.5%
- Return on assets
- -2.3%
Balance sheet and cash flow
- Cash
- $195m
- Cash per share
- $0.98
- Financial debt
- $2.20bn
- Debt/equity %
- 162
- Current ratio
- 1.63
- Book value per share
- $6.84
- Operating cash flow
- $272m
- Free cash flow
- $103m
Dividend
- Dividend yield
- 1.93%
- Dividend (12 months)
- $0.16
- Yield (12 months)
- 1.93%
- Payout ratio
- –
- Ex-dividend date
- 26 Dec 2025
Shares and trading
- Shares outstanding
- 198m
- Volume
- 4.88m
- Avg. volume 3 months
- 4.69m
- Relative volume
- 1.0
Price and technicals
- Price
- $8.29
- 1 day
- −2.4%
- 52-week high
- $14.68
- 52-week low
- $8.29
- Distance to 52-week high
- −43.5%
- Distance to 52-week low
- 0.0%
- Distance to 50-day line
- −10.0%
- Distance to 200-day line
- −25.3%
- RSI (14)
- 35
- Volatility 1M
- 54.5%
Performance
- 1 week
- −9.5%
- 1 month
- −12.7%
- 3 months
- −23.9%
- 6 months
- −18.8%
- YTD
- −27.5%
- 1 year
- −17.8%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has XRAY performed since 11/2016?
$10,000 grew to $1,593 by 20 Nov 2026, which is −16.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is XRAY?
Volatility was 32.3% per year, measured on monthly returns. The largest decline from a peak was −86.6%, with the low in 11/2026.
How does XRAY compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, XRAY returned −16.8% at 32.3%. The correlation of monthly returns was 0.49; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.